IPSC - Century Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$2.00
DETAILS
HIGH:
$2.00
LOW:
$2.00
MEDIAN:
$2.00
CONSENSUS:
$2.00
DOWNSIDE:
3.38%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 109.2 | 6.6 | 2.2 | 5.2 | 0 | 0 | 0 |
| Cost of Revenue | 13.1 | 0 | 0 | 0 | 4.6 | 1.8 | 0.2 |
| Gross Profit | 96.1 | 6.6 | 2.2 | 5.2 | (4.6) | (1.8) | (0.2) |
| Operating Expenses | |||||||
| R&D Expenses | 95.7 | 107.2 | 92.7 | 97.2 | 75.6 | 39.7 | 14.3 |
| SG&A Expenses | 24.0 | 33.2 | 34.7 | 31.9 | 14.7 | 7.7 | 5.5 |
| Other Expenses | (8.6) | 4.3 | 21.4 | 10 | 0 | 0 | 0 |
| Operating Expenses | 111.1 | 144.7 | 148.8 | 139.0 | 90.3 | 47.4 | 19.8 |
| Operating Income | |||||||
| Operating Income | (15.0) | (138.1) | (146.5) | (133.8) | (94.9) | (49.2) | (20.0) |
| Interest Expense | 0 | 0 | 0.5 | 0 | 1.3 | 0.4 | 0 |
| Interest Income | 7.3 | 13.0 | 12.7 | 3.0 | 0.9 | 0.7 | 1.2 |
| Profitability | |||||||
| EBITDA | 3.5 | (111.5) | (121.2) | (121.2) | (89.9) | (51.4) | (244.5) |
| EBIT | (9.6) | (124.8) | (134.3) | (129.6) | (94.5) | (53.2) | (244.8) |
| Income Before Tax | (9.6) | (124.8) | (134.8) | (130.8) | (95.8) | (53.6) | (244.8) |
| Income Tax Expense | (0.1) | 1.8 | 1.9 | 0.1 | 0.0 | 0 | 0 |
| Net Income | (9.6) | (126.6) | (136.7) | (130.9) | (95.8) | (53.6) | (244.8) |
| Per Share Data | |||||||
| EPS (Basic) | -0.11 | -1.61 | -2.30 | -2.27 | -1.74 | -1.00 | -4.49 |
| EPS (Diluted) | -0.11 | -1.61 | -2.30 | -2.27 | -1.74 | -1.00 | -4.49 |
| Shares Outstanding | 86.6 | 78.6 | 59.3 | 57.8 | 55.0 | 54.8 | 54.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 61.9 | 58.4 | 47.3 | 84.3 | 56.4 | 27.2 | 44.1 |
| Short-Term Investments | 55.3 | 130.9 | 125.4 | 231.2 | 166.4 | 48.5 | 37.5 |
| Net Receivables | 0.7 | 1.5 | 0.7 | 0.8 | 0.2 | 0.9 | 0.1 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.7 | 0.9 | 1.8 | 0.5 | 2.8 | 1.8 | 0.3 |
| Total Current Assets | 120.8 | 194.1 | 177.0 | 319.7 | 228.2 | 78.8 | 84.1 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 66.2 | 90.8 | 92.1 | 111.7 | 69.8 | 24.8 | 2.5 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 34.2 | 34.2 | 0 | 0 | 0 | 9.4 | 0 |
| Long-Term Investments | 2.4 | 30.8 | 91.1 | 51.9 | 135.9 | 1.1 | 4.1 |
| Other Non-Current Assets | 0.2 | 3.3 | 0.5 | 3.2 | 3.5 | (7.2) | 0.2 |
| Total Non-Current Assets | 102.9 | 159.2 | 183.7 | 166.8 | 209.2 | 28.0 | 6.8 |
| Total Assets | 223.7 | 353.2 | 360.7 | 486.5 | 437.4 | 106.8 | 90.9 |
| Current Liabilities | |||||||
| Account Payables | 4.8 | 3.1 | 2.7 | 5.5 | 7.6 | 8.1 | 1.5 |
| Short-Term Debt | 0 | 0 | 1.5 | 6.5 | 1.0 | 0 | 0 |
| Deferred Revenue | 0 | 109.2 | 4.4 | 7.2 | 0 | 0 | 0 |
| Other Current Liabilities | 3.8 | 0.1 | 2.7 | 3.2 | 1.1 | 0.1 | 0.1 |
| Total Current Liabilities | 20.2 | 129.8 | 17.8 | 29.8 | 15.7 | 12.1 | 3.0 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 0 | 0 | 0 | 3.7 | 8.9 | 9.6 | 0 |
| Deferred Tax Liabilities | 4.3 | 4.4 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 8.7 | 0.1 | 0.7 | 2.0 | 179.8 | 179.8 |
| Total Non-Current Liabilities | 44.5 | 62.1 | 158.1 | 154.0 | 25.5 | 201.1 | 179.8 |
| Total Liabilities | 64.8 | 191.9 | 175.9 | 183.8 | 41.1 | 213.2 | 182.8 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (791.9) | (782.3) | (655.8) | (519.1) | (388.2) | (292.3) | (238.8) |
| Accumulated Other Comprehensive Income | 0.0 | 0.3 | 0.1 | (2.5) | (0.7) | (0.0) | (0.0) |
| Total Stockholders' Equity | 158.9 | 161.4 | 184.8 | 302.7 | 396.2 | (106.4) | (91.9) |
| Total Liabilities & Equity | 223.7 | 353.2 | 360.7 | 486.5 | 437.4 | 106.8 | 90.9 |
| Debt Metrics | |||||||
| Total Debt | 43.6 | 53.8 | 48.2 | 49.4 | 25.1 | 21.6 | 0 |
| Net Debt | (18.3) | (4.6) | 0.8 | (34.9) | (31.3) | (5.7) | (44.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (9.6) | (126.6) | (136.7) | (130.9) | (95.8) | (53.6) | (244.8) |
| Depreciation & Amortization | 13.1 | 13.3 | 13.0 | 8.4 | 3.7 | 1.4 | 0.2 |
| Stock-Based Compensation | 6.8 | 12.7 | 14.6 | 10.7 | 4.7 | 0.9 | 0.1 |
| Change in Working Capital | (114.6) | (9.3) | 9.4 | 123.9 | (2.8) | 4.9 | 2.3 |
| Other Non-Cash Items | 0.4 | (1.2) | 11.3 | 1.9 | 1.2 | 5.2 | 225.9 |
| Operating Cash Flow | (103.9) | (110.1) | (88.3) | 14.1 | (89.0) | (41.3) | (16.2) |
| Investing Activities | |||||||
| Capital Expenditure | (0.8) | (0.2) | (13.7) | (30.6) | (45.0) | (9.8) | (2.5) |
| Acquisitions | 0 | (9.6) | 0 | (238.2) | 0 | 0 | 0 |
| Purchases of Investments | (51.2) | (119.5) | (209.0) | (254) | (330.0) | (49.9) | (41.5) |
| Sales/Maturities of Investments | (51.2) | 176.8 | 283.9 | 271.5 | 76.7 | 41.6 | 0 |
| Other Investing Activities | 210.7 | 0 | 0 | 238.2 | 0 | (4.7) | 24.2 |
| Investing Cash Flow | 107.5 | 47.5 | 61.1 | (13.1) | (298.3) | (22.8) | (19.8) |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | (10.2) | 0 | 0 | 9.7 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 36.5 | 38.0 | 0 |
| Financing Cash Flow | 0.2 | 74.6 | (9.7) | 27.2 | 417.8 | 47.7 | 74.8 |
| Cash Position | |||||||
| Net Change in Cash | 3.8 | 11.9 | (36.9) | 28.1 | 30.4 | (16.3) | 38.8 |
| Cash at Beginning | 61.2 | 49.3 | 86.2 | 58.2 | 27.7 | 44.1 | 31.4 |
| Cash at End | 65.0 | 61.2 | 49.3 | 86.2 | 58.2 | 27.7 | 70.3 |
| Free Cash Flow | (104.7) | (110.3) | (102.1) | (16.6) | (134.0) | (51.1) | (18.6) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 109.2 | 6.6 | 2.2 | 5.2 | 0 | 0 | 0 |
| Gross Profit | 96.1 | 6.6 | 2.2 | 5.2 | (4.6) | (1.8) | (0.2) |
| Operating Income | (15.0) | (138.1) | (146.5) | (133.8) | (94.9) | (49.2) | (20.0) |
| Net Income | (9.6) | (126.6) | (136.7) | (130.9) | (95.8) | (53.6) | (244.8) |
| EPS (Diluted) | -0.11 | -1.61 | -2.30 | -2.27 | -1.74 | -1.00 | -4.49 |
| Balance Sheet | |||||||
| Cash & Equivalents | 61.9 | 58.4 | 47.3 | 84.3 | 56.4 | 27.2 | 44.1 |
| Total Assets | 223.7 | 353.2 | 360.7 | 486.5 | 437.4 | 106.8 | 90.9 |
| Total Debt | 43.6 | 53.8 | 48.2 | 49.4 | 25.1 | 21.6 | 0 |
| Stockholders' Equity | 158.9 | 161.4 | 184.8 | 302.7 | 396.2 | (106.4) | (91.9) |
| Cash Flow | |||||||
| Operating Cash Flow | (103.9) | (110.1) | (88.3) | 14.1 | (89.0) | (41.3) | (16.2) |
| Capital Expenditure | (0.8) | (0.2) | (13.7) | (30.6) | (45.0) | (9.8) | (2.5) |
| Free Cash Flow | (104.7) | (110.3) | (102.1) | (16.6) | (134.0) | (51.1) | (18.6) |